Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 2
1991 5
1992 3
1993 1
1999 1
2008 2
2009 1
2010 3
2011 1
2012 3
2013 1
2014 2
2015 3
2016 2
2017 4
2018 5
2019 5
2020 3
2021 2
2022 4
2023 4
2024 2
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).
Iland HJ, Bradstock K, Supple SG, Catalano A, Collins M, Hertzberg M, Browett P, Grigg A, Firkin F, Hugman A, Reynolds J, Di Iulio J, Tiley C, Taylor K, Filshie R, Seldon M, Taper J, Szer J, Moore J, Bashford J, Seymour JF; Australasian Leukaemia and Lymphoma Group. Iland HJ, et al. Among authors: tiley c. Blood. 2012 Aug 23;120(8):1570-80; quiz 1752. doi: 10.1182/blood-2012-02-410746. Epub 2012 Jun 19. Blood. 2012. PMID: 22715121 Free article. Clinical Trial.
Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG.
Loo S, Roberts AW, Anstee NS, Kennedy GA, He S, Schwarer AP, Enjeti AK, D'Rozario J, Marlton P, Bilmon IA, Taper J, Cull G, Tiley C, Verner E, Hahn U, Hiwase DK, Iland HJ, Murphy N, Ramanathan S, Reynolds J, Ong DM, Tiong IS, Wall M, Murray M, Rawling T, Leadbetter J, Rowley L, Latimer M, Yuen S, Ting SB, Fong CY, Morris K, Bajel A, Seymour JF, Levis MJ, Wei AH. Loo S, et al. Among authors: tiley c. Blood. 2023 Dec 7;142(23):1960-1971. doi: 10.1182/blood.2023020301. Blood. 2023. PMID: 37647654 Free PMC article. Clinical Trial.
How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials?
Tiong IS, Wall M, Bajel A, Kalro A, Fleming S, Roberts AW, Thiagarajah N, Chua CC, Latimer M, Yeung D, Marlton P, Johnston A, Enjeti A, Fong CY, Cull G, Larsen S, Kennedy G, Schwarer A, Kipp D, Ramanathan S, Verner E, Tiley C, Morris E, Hahn U, Moore J, Taper J, Purtill D, Warburton P, Stevenson W, Murphy N, Tan P, Beligaswatte A, Mutsando H, Hertzberg M, Shortt J, Szabo F, Dunne K, Wei AH; Australasian Leukaemia and Lymphoma Group (ALLG). Tiong IS, et al. Among authors: tiley c. Blood Cancer J. 2024 Mar 26;14(1):54. doi: 10.1038/s41408-024-00996-x. Blood Cancer J. 2024. PMID: 38531863 Free PMC article.
Clinical response to azacitidine in MDS is associated with distinct DNA methylation changes in HSPCs.
Thoms JAI, Yan F, Hampton HR, Davidson S, Joshi S, Saw J, Sarowar CH, Lim XY, Nunez AC, Kakadia PM, Bhuyan GS, Zou X, Nguyen M, Ghodousi ES, Koch FC, Vafaee F, Thompson IR, Karimi MM, Pickford R, Raftery MJ, Hough S, Buckland G, Bailey M, Ghodke Y, Absar N, Vaughan L, Pasalic L, Fong CY, Kenealy M, Hiwase DK, Stoddart RI, Mohammed S, Lee L, Passam FH, Larsen SR, Spring KJ, Skarratt KK, Rebeiro P, Presgrave P, Stevenson WS, Ling S, Tiley C, Fuller SJ, Roncolato F, Enjeti AK, Hoenemann D, Lemech C, Jolly CJ, Bohlander SK, Curtis DJ, Wong JWH, Unnikrishnan A, Hertzberg M, Olivier J, Polizzotto MN, Pimanda JE. Thoms JAI, et al. Among authors: tiley c. Nat Commun. 2025 May 13;16(1):4451. doi: 10.1038/s41467-025-59796-x. Nat Commun. 2025. PMID: 40360497 Free PMC article. Clinical Trial.
Three types of agnosia.
Tiley C. Tiley C. Br J Gen Pract. 2021 Jan 28;71(703):77. doi: 10.3399/bjgp21X714797. Print 2021. Br J Gen Pract. 2021. PMID: 33509822 Free PMC article. No abstract available.
Occupational exposure to extremely low-frequency magnetic fields and follicular lymphoma risk: a family case-control study.
Odutola MK, van Leeuwen MT, Bruinsma FJ, Benke G, Turner MC, Trotman J, Turner J, Seymour JF, Prince HM, Milliken ST, Tiley C, Hertzberg M, Roncolato F, Opat S, Lindeman R, Verner E, Underhill CR, Cardis E, Giles G, Vajdic CM. Odutola MK, et al. Among authors: tiley c. Occup Environ Med. 2023 Oct;80(10):599-602. doi: 10.1136/oemed-2023-108949. Epub 2023 Sep 18. Occup Environ Med. 2023. PMID: 37722828 Free PMC article.
'Real-world' Australian experience of pomalidomide for relapsed and refractory myeloma.
Scott A, Weber N, Tiley C, Taylor K, Taper J, Harrison S, Chan KL, Stark R, Lee C, Morris K, Ho PJ, Dodds A, Ramanathan S, Ramakrishna R, Watson AM, Auguston B, Kwok F, Quach H, Warburton P, Rowlings P, Mollee P. Scott A, et al. Among authors: tiley c. Leuk Lymphoma. 2018 Jun;59(6):1514-1516. doi: 10.1080/10428194.2017.1387911. Epub 2017 Oct 12. Leuk Lymphoma. 2018. PMID: 29022836 No abstract available.
Raccoon eyes in systemic light chain amyloidosis.
Forsyth CJ, Tiley CR. Forsyth CJ, et al. Among authors: tiley cr. Med J Aust. 2017 May 15;206(9):384. doi: 10.5694/mja16.00848. Med J Aust. 2017. PMID: 28490298 No abstract available.
A Population-Based Family Case-Control Study of Sun Exposure and Follicular Lymphoma Risk.
Odutola MK, van Leeuwen MT, Bruinsma F, Turner J, Hertzberg M, Seymour JF, Prince HM, Trotman J, Verner E, Roncolato F, Opat S, Lindeman R, Tiley C, Milliken ST, Underhill CR, Benke G, Giles GG, Vajdic CM. Odutola MK, et al. Among authors: tiley c. Cancer Epidemiol Biomarkers Prev. 2024 Jan 9;33(1):106-116. doi: 10.1158/1055-9965.EPI-23-0578. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 37831120 Free PMC article.
52 results